Molecular Drug Targets in Myeloproliferative Neoplasms: Mutant ABL1, JAK2, MPL, KIT, PDGFRA, PDGFRB and FGFR1
Journal of Cellular and Molecular Medicine - United Kingdom
doi 10.1111/j.1582-4934.2008.00559.x
Full Text
Open PDFAbstract
Available in full text
Date
October 23, 2008
Authors
Publisher
Wiley